The U.S. biotech company Spyre Therapeutics announced yesterday that it has dosed the first participants in two Phase 1 ...

Sanjay K. Murthy, MD, MSc (Epid), talked with Physician’s Weekly about changes in digestive cancer types among patients with ...

In fact, as many as 35% of people with IBD have some kind of oral manifestation of the condition, such as canker sores, the ...

Cases of inflammatory bowel disease (IBD) are rising at an alarming rate among young Americans, a new study reveals.

J&J files for FDA approval of Tremfya for plaque psoriasis and psoriatic arthritis indications in pediatric patients ...

An exclusive report shown to ITV News found that none of the IBD services across the UK met standards with patient care ...